Our easy, non-invasive process preserves diverse cell types found in your hair follicles, ready for future skin, hair, and sports performance enhancements ensuring you have access to personalized regenerative treatments and optimal results in the future when you need them most.
As aging progresses, so does cellular aging. We empower your personalized regenerative journey by preserving your entire hair follicle. Our collection preserves cell types like Keratinocytes, Fibroblasts and Mesenchymal Stem Cells (MSCs), ensuring that as regenerative treatments advance, you have access to a diverse range of preserved cell types.
With Acorn, you’re not limited by what’s available today – you’re prepared for the breakthroughs of tomorrow.
Preserve your best cells and save with long-term storage with our most popular monthly package for $85+ tax.
Package Includes:
- Acorn Collection
- Viability Report
- Lifetime Storage Plan
Plus, early access to Acorn's product launches and join Acorn's insider Anti-Aging Aging Club for additional benefits.
Cell Viability guaranteed
.png)
Average number of hairs on the head
Follicles collected for Acorn cell preservation
Average number of hairs on the head
Different cell types are found in the hair follicle
The primary cells that produce the surface level of your skin.
Sub-dermal tissue layer cells that play a role in producing collagen and elastin.
Progenitor cells that can become a wide variety of cells in your body.
By preserving your entire hair follicle now, you're safeguarding a diverse range of cell types, including Keratinocytes, Fibroblasts, and Mesenchymal Stem Cells (MSCs).
Keratinocytes, the primary cell type in the epidermis, have demonstrated remarkable efficacy in clinical trials for treating various skin conditions. These cells are essential for maintaining skin barrier function and promoting wound healing.
Potential applications: treating burns, venous ulcers, and diabetic ulcers, ensuring effective healing and tissue repair.
Fibroblasts, the main cell type in the dermis, play a pivotal role in wound healing and tissue repair. These cells are responsible for producing collagen, elastin, and other extracellular matrix components that provide structural support to the skin.
Potential applications: future treatments aimed at reducing scarring and enhancing your body's natural healing processes.
MSCs, found in various tissues including bone marrow and adipose tissue, are multipotent stem cells with the ability to differentiate into a wide array of cell types.
Potential Applications:
We are committed to pioneering the future of healthcare through science-led and research-backed innovations. Supported by leading medical and aesthetic organizations, we collaborate with top Canadian universities to advance the field of cryopreserved cell research.
Stem cell therapy is at the forefront of medical research, with over 8,300 active clinical trials globally. These trials encompass a wide range of treatments, from regenerative medicine and oncology to rare genetic disorders and chronic diseases. This extensive research network spans leading hospitals, research institutions, and biotech companies, highlighting the collaborative efforts to unlock new therapies and improve patient outcomes.
Stage III clinical trials are critical for determining the efficacy and safety of new treatments before they can receive regulatory approval. As of 2024, there are over 240 active Stage III clinical trials focused on stem cell therapies. These trials represent the final step before potential treatments can be brought to market, offering hope for effective solutions to some of the most challenging medical conditions. The success of these trials could lead to groundbreaking advancements in healthcare.
The regenerative medicine market is projected to reach a staggering $174 billion by 2032. This growth is driven by advancements in stem cell therapies, increased investment in research and development, and the rising prevalence of chronic diseases and aging populations. Key treatments and applications anticipated to come to market by 2032 include:
"This is the future of longevity. The work Acorn is doing is highly scientific, evidence-based, and truly impressive."
Acorn provides a proactive solution, preserving and unlocking our regenerative potential. This, to me, represents the most exciting frontier in the future of medicine. I very excited about banking my cells and equally excited for my patients to access Acorn.
"We’re on the cusp of a new era in medical treatments. The possibilities of using these banked stem cells in the future, not only for hair restoration but for a range of regenerative medicine applications, are vast and exciting."
.png){kind=small}
